U.S. flag

An official website of the United States government

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Links from MedGen

Items: 1 to 20 of 1000

1.
Testing for HCV Infection: An Update of Guidance for Clinicians and Laboratorians
Jane P. Getchell, Kelly E. Wroblewski, Alfred DeMaria, Jr, Christine L. Bean, Monica M. Parker, Mark Pandori, D. Robert Dufour, Michael P. Busch, Mark E. Brecher, William A. Meyer, Rick L. Pesano, Chong-Gee Teo, Geoffrey A. Beckett, Aufra C. Araujo, Bernard M. Branson, Jan Drobeniuc, Rikita Hatia, Scott D. Holmberg, Saleem Kamili, John W. Ward
MMWR Morb Mortal Wkly Rep. 2013 May 10; 62(18): 362–365. Published online 2013 May 10.
PMCID:
PMC4605020
ArticlePDF–237K
2.
HCV Council – critical appraisal of data: recommendations for clinical practice in a rapidly evolving therapeutic landscape
Nancy Reau, Michael W. Fried, David R. Nelson, Robert S. Brown, Jr, Gregory T. Everson, Stuart C. Gordon, Ira M. Jacobson, Joseph K. Lim, Paul J. Pockros, K. Rajender Reddy, Kenneth E. Sherman
Liver Int. 2016 Apr; 36(4): 488–502. Published online 2015 Nov 22. doi: 10.1111/liv.12993
PMCID:
PMC5063106
AbstractArticlePDF–1.3M
3.
APASL clinical practice recommendation: how to treat HCV-infected patients with renal impairment?
Tatsuo Kanda, George K. K. Lau, Lai Wei, Mitsuhiko Moriyama, Ming-Lung Yu, Wang-Long Chuang, Alaaeldin Ibrahim, Cosmas Rinaldi Adithya Lesmana, Jose Sollano, Manoj Kumar, Ankur Jindal, Barjesh Chander Sharma, Saeed S. Hamid, A. Kadir Dokmeci, Mamun-Al-Mahtab, Geofferey W. McCaughan, Jafri Wasim, Darrell H. G. Crawford, Jia-Horng Kao, Osamu Yokosuka, Shiv Kumar Sarin, Masao Omata
Hepatol Int. 2019 Mar; 13(2): 103–109. Published online 2018 Dec 11. doi: 10.1007/s12072-018-9915-5
PMCID:
PMC6418053
AbstractArticlePDF–793K
4.
APASL HCV guidelines of virus-eradicated patients by DAA on how to monitor HCC occurrence and HBV reactivation
Tatsuo Kanda, George K. K. Lau, Lai Wei, Mitsuhiko Moriyama, Ming-Lung Yu, Wang-Long Chuang, Alaaeldin Ibrahim, Cosmas Rinaldi Adithya Lesmana, Jose Sollano, Manoj Kumar, Ankur Jindal, Barjesh Chander Sharma, Saeed S. Hamid, A. Kadir Dokmeci, Mamun-Al-Mahtab, Geoffrey W. McCaughan, Jafri Wasim, Darrell H. G. Crawford, Jia-Horng Kao, Yoshihiko Ooka, Osamu Yokosuka, Shiv Kumar Sarin, Masao Omata
Hepatol Int. 2019 Nov; 13(6): 649–661. Published online 2019 Sep 20. doi: 10.1007/s12072-019-09988-7
PMCID:
PMC6861433
AbstractArticlePDF–944K
5.
Incidence of hepatocellular carcinoma in a community-based Taiwanese population without chronic HBV/HCV infection
Hui-Chen Wu, Wen-Juei Jeng, Mei-Hung Pan, Yi-Chung Hsieh, Sheng-Nan Lu, Chien-Jen Chen, Hwai-I. Yang
JHEP Rep. 2022 Feb; 4(2): 100410. Published online 2021 Nov 24. doi: 10.1016/j.jhepr.2021.100410
PMCID:
PMC8777288
AbstractArticlePDF–402K
6.
HCV Interplay With Mir34a: Implications in Hepatocellular Carcinoma
Ester Badami, Claudia Carcione, Cinzia Maria Chinnici, Rosaria Tinnirello, Pier Giulio Conaldi, Gioacchin Iannolo
Front Oncol. 2021; 11: 803278. Published online 2022 Jan 19. doi: 10.3389/fonc.2021.803278
PMCID:
PMC8812294
AbstractArticlePDF–2.0M
7.
G-Computation to Causal Mediation Analysis With Sequential Multiple Mediators—Investigating the Vulnerable Time Window of HBV Activity for the Mechanism of HCV Induced Hepatocellular Carcinoma
An-Shun Tai, Yen-Tsung Huang, Hwai-I Yang, Lauren V. Lan, Sheng-Hsuan Lin
Front Public Health. 2021; 9: 757942. Published online 2022 Jan 7. doi: 10.3389/fpubh.2021.757942
PMCID:
PMC8779208
AbstractArticlePDF–622K
8.
HCV Genotype Has No Influence on the Incidence of Diabetes—EpiTer Multicentre Study
Paweł Rajewski, Dorota Zarębska-Michaluk, Ewa Janczewska, Andrzej Gietka, Włodzimierz Mazur, Magdalena Tudrujek-Zdunek, Krzysztof Tomasiewicz, Teresa Belica-Wdowik, Barbara Baka-Ćwierz, Dorota Dybowska, Waldemar Halota, Beata Lorenc, Marek Sitko, Aleksander Garlicki, Hanna Berak, Andrzej Horban, Iwona Orłowska, Krzysztof Simon, Łukasz Socha, Marta Wawrzynowicz-Syczewska, Jerzy Jaroszewicz, Zbigniew Deroń, Agnieszka Czauż-Andrzejuk, Jolanta Citko, Rafał Krygier, Anna Piekarska, Łukasz Laurans, Witold Dobracki, Jolanta Białkowska, Olga Tronina, Magdalena Wietlicka-Piszcz, Małgorzata Pawłowska, Robert Flisiak
J Clin Med. 2022 Jan; 11(2): 379. Published online 2022 Jan 13. doi: 10.3390/jcm11020379
PMCID:
PMC8780546
AbstractArticlePDF–261K
9.
Pangenotypic and Genotype-Specific Antivirals in the Treatment of HCV Genotype 4 Infected Patients with HCV Monoinfection and HIV/HCV Coinfection
Dorota Zarębska-Michaluk, Jerzy Jaroszewicz, Anna Parfieniuk-Kowerda, Małgorzata Pawłowska, Ewa Janczewska, Hanna Berak, Justyna Janocha-Litwin, Jakub Klapaczyński, Krzysztof Tomasiewicz, Anna Piekarska, Rafał Krygier, Jolanta Citko, Olga Tronina, Krystyna Dobrowolska, Robert Flisiak
J Clin Med. 2022 Jan; 11(2): 389. Published online 2022 Jan 13. doi: 10.3390/jcm11020389
PMCID:
PMC8781964
AbstractArticlePDF–2.4M
10.
Special Issue “Chronic HCV Infection: Clinical Advances and Eradication Perspectives”
Maria Carla Liberto, Nadia Marascio
J Clin Med. 2022 Jan; 11(2): 359. Published online 2022 Jan 12. doi: 10.3390/jcm11020359
PMCID:
PMC8781993
ArticlePDF–166K
11.
Linkage-to-Care Following Community-Based HBV and HCV Screening Among Immigrants from the Washington–Baltimore Metropolitan Area, 2016–2019
Daisy Le, Annie Coriolan Ciceron, Jane Pan, Hee-Soon Juon, Carla J. Berg, T. Angeline Nguyen, Hai Chi Le, Y. Tony Yang
J Immigr Minor Health. 2022; 24(5): 1137–1144. Published online 2022 Jan 22. doi: 10.1007/s10903-022-01327-7
PMCID:
PMC8783186
AbstractArticlePDF–674K
12.
Prevalence and genotype distribution of hepatitis C virus within hemodialysis units in Thailand: role of HCV core antigen in the assessment of viremia
Natthaya Chuaypen, Apichaya Khlaiphuengsin, Thaninee Prasoppokakorn, Paweena Susantitaphong, Wisit Prasithsirikul, Anchalee Avihingsanon, Pisit Tangkijvanich, Kearkiat Praditpornsilpa
BMC Infect Dis. 2022; 22: 79. Published online 2022 Jan 22. doi: 10.1186/s12879-022-07074-2
PMCID:
PMC8783655
AbstractArticlePDF–1.5M
13.
Baseline Plasma Metabotype Correlates With Direct-Acting Antiviral Therapy Nonresponse for HCV in HIV–HCV Coinfected Patients
Gaurav Tripathi, Sheetalnath Rooge, Manisha Yadav, Babu Mathew, Nupur Sharma, Vasundhra Bindal, Hamed Hemati, Jaswinder Singh Maras, Ekta Gupta
Front Mol Biosci. 2021; 8: 748014. Published online 2022 Jan 10. doi: 10.3389/fmolb.2021.748014
PMCID:
PMC8784690
AbstractArticlePDF–3.4M
14.
Efficacy of Antiviral Treatment in Hepatitis C Virus (HCV)-Driven Monoclonal Gammopathies Including Myeloma
Alba Rodríguez-García, María Linares, María Luz Morales, Sophie Allain-Maillet, Nicolas Mennesson, Ricardo Sanchez, Rafael Alonso, Alejandra Leivas, Alfredo Pérez-Rivilla, Edith Bigot-Corbel, Sylvie Hermouet, Joaquín Martínez-López
Front Immunol. 2021; 12: 797209. Published online 2022 Jan 11. doi: 10.3389/fimmu.2021.797209
PMCID:
PMC8786723
AbstractArticlePDF–2.3M
15.
Machine learning for mathematical models of HCV kinetics during antiviral therapy
Alexander Churkin, Stephanie Kriss, Asher Uziel, Ashish Goyal, Rami Zakh, Scott J. Cotler, Ohad Etzion, Amir Shlomai, Horacio G. Rotstein, Harel Dahari, Danny Barash
Math Biosci. Author manuscript; available in PMC 2023 Jan 1.
Published in final edited form as: Math Biosci. 2022 Jan; 343: 108756. Published online 2021 Dec 6. doi: 10.1016/j.mbs.2021.108756
PMCID:
PMC8792269
AbstractArticlePDF–1.3M
16.
Clinical outcomes after treatment with direct antiviral agents: beyond the virological response in patients with previous HCV-related decompensated cirrhosis
Georges-Philippe Pageaux, Clovis Lusivika Nzinga, Nathalie Ganne, Didier Samuel, Céline Dorival, Fabien Zoulim, Carole Cagnot, Thomas Decaens, Dominique Thabut, Tarik Asselah, Philippe Mathurin, François Habersetzer, Jean-Pierre Bronowicki, Dominique Guyader, Isabelle Rosa, Vincent Leroy, Olivier Chazouilleres, Victor de Ledinghen, Marc Bourliere, Xavier Causse, Paul Cales, Sophie Metivier, Véronique Loustaud-Ratti, Ghassan Riachi, Laurent Alric, Moana Gelu-Simeon, Anne Minello, Jérôme Gournay, Claire Geist, Albert Tran, Armand Abergel, Isabelle Portal, Louis d’Alteroche, François Raffi, Hélène Fontaine, Fabrice Carrat, Stanislas Pol, For the French ANRS CO22 Hepather Cohort
BMC Infect Dis. 2022; 22: 94. Published online 2022 Jan 27. doi: 10.1186/s12879-022-07076-0
PMCID:
PMC8796427
AbstractArticlePDF–810K
17.
Effectiveness of the HCV blood screening strategy through eighteen years of surveillance of HCV infection in blood donors in France
Pierre Cappy, Laure Boizeau, Daniel Candotti, Rémi Caparros, Quentin Lucas, Eliane Garrabe, Christophe Martinaud, Sophie Le Cam, Pierre Gallian, Pascal Morel, Josiane Pillonel, Syria Laperche
Blood Transfus. 2022 Jan; 20(1): 1–7. Prepublished online 2021 May 12. doi: 10.2450/2021.0032-21
PMCID:
PMC8796843
AbstractArticlePDF–674K
18.
Direct antiviral agents for HCV infection and hepatocellular carcinoma: facts and FADs
Ilaria Serio, Lucia Napoli, Simona Leoni, Fabio Piscaglia
Transl Cancer Res. 2019 Apr; 8(Suppl 3): S223–S232. doi: 10.21037/tcr.2019.04.01
PMCID:
PMC8798330
AbstractArticlePDF–219K
19.
Distribution of hepatitis C virus (HCV) genotypes in a Saudi Arabian hospital during the 2015–2020 period
Fadel Ali M. Almosa, Ali Hassan A. Alnasser, Jaffar A. Al-Tawfiq
Infez Med. 2021; 29(3): 450–455. Published online 2021 Sep 10. doi: 10.53854/liim-2903-16
PMCID:
PMC8805486
AbstractArticlePDF–826K
20.
Derivation of “Egyptian varices prediction (EVP) index”: A novel noninvasive index for diagnosing esophageal varices in HCV Patients
Shimaa M. Abd-Elsalam, Mohamed M. Ezz, Shehab Gamalel-Din, Gamal Esmat, Wafaa Elakel, Mahmoud ElHefnawi
J Adv Res. 2022 Jan; 35: 87–97. Published online 2021 Feb 24. doi: 10.1016/j.jare.2021.02.005
PMCID:
PMC8721354
AbstractArticlePDF–1.3M

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Filter your results:

Find related data

Recent activity

Clear Turn Off Turn On

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...
You are here: NCBI > Literature > PubMed Central (PMC)
Support Center